Dysmenorrhea and endometriosis in teenage girls (review)

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access


Most adolescents experience discomfort during menstruation. Usually, girls are diagnosed with primary dysmenorrhea in the early reproductive period and respond well to symptomatic treatment with non-steroidal anti-inflammatory or hormonal drugs. If first-line therapy does not improve the symptoms of dysmenorrhea, transabdominal ultrasonography is indicated. Most often, these patients are diagnosed with endometriosis, which is the main cause of secondary dysmenorrhea in adolescents. Endometriosis should be assumed in patients with persistent, clinically pronounced dysmenorrhea that does not respond to treatment with hormonal drugs and non-steroidal anti-inflammatory drugs, especially if no other cause of chronic pelvic pain or secondary dysmenorrhea is detected on the basis of history, physical examination, and ultrasonography of pelvic organs. The aim of the therapy is to relieve symptoms, suppress disease progression, and protect future fertility.

Full Text

Restricted Access

About the authors

Ara L. Unanyan

I.M. Sechenov First Moscow State Medical University

Author for correspondence.
Email: 9603526@mail.ru
ORCID iD: 0000-0002-2283-2356

MD, Dr. Sci. (Med.), professor; address

Russian Federation, 119991, Moscow

Laura G. Pivazyan

.M. Sechenov First Moscow State Medical University

Email: laurapivazyan98@gmail.com
ORCID iD: 0000-0002-6844-3321

V-year student

Russian Federation, 119991, Moscow

Dzhulietta S. Avetisyan

I.M. Sechenov First Moscow State Medical University

Email: julietavetisian@mail.ru

IV-year student

Russian Federation, 119991, Moscow

Archil A. Siordiya

I.M. Sechenov First Moscow State Medical University

Email: 9603526@mail.ru

MD, Cand. Sci. (Med.), assistant professor

Russian Federation, 119991, Moscow

Anatoliy I. Ishchenko

I.M. Sechenov First Moscow State Medical University

Email: 9603526@mail.ru
ORCID iD: 0000-0003-3338-1113

MD, Dr. Sci. (Med.), Professor

Russian Federation, 119991, Moscow


  1. ACOG Committee Opinion No. 760: Dysmenorrhea and Endometriosis in the Adolescent. Obstet Gynecol. 2018;132(6):e249–e258. doi: 10.1097/AOG.0000000000002978
  2. Sachedina A, Todd N. Dysmenorrhea, endometriosis and chronic pelvic pain in adolescents. J Clin Res Pediatr Endocrinol. 2020;12 Suppl.1:7–17. doi: 10.4274/jcrpe.galenos.2019.2019.S0217
  3. Burnett M, Lemyre M. No. 345-Primary Dysmenorrhea Consensus Guideline. J Obstet Gynaecol Can. 2017;39(7):585–595. doi: 10.1016/j.jogc.2016.12.023
  4. Hewitt G. Dysmenorrhea and endometriosis: diagnosis and management in adolescents. Clin Obstet Gynecol. 2020;63(3):536–543. doi: 10.1097/GRF.0000000000000540
  5. Zannoni L, Giorgi M, Spagnolo E, et al. Dysmenorrhea, absenteeism from school, and symptoms suspicious for endometriosis in adolescents. J Pediatr Adolesc Gynecol. 2014;27(5):258–265. doi: 10.1016/j.jpag.2013.11.008
  6. Adeyemi-Fowode OA, Bercaw-Pratt JL. Intrauterine devices: effective contraception with noncontraceptive benefits for adolescents. J Pediatr Adolesc Gynecol. 2019;32:2–6. doi: 10.1016/j.jpag.2019.07.001
  7. Smith CA, Armour M, Zhu X, et al. Acupuncture for dysmenorrhoea. Cochrane Database Syst Rev. 2016;4:CD007854. doi: 10.1002/14651858.CD007854.pub3
  8. Siedentopf F, Weijenborg P, Engman M, et al. ISPOG European Consensus Statement ― chronic pelvic pain in women (short version). J Psychosom Obstet Gynaecol. 2015;36(4):161–170. doi: 10.3109/0167482X.2015.1103732
  9. Royal College of Obstetricians and Gynaecologists. The initial management of chronic pelvic pain. Green-top Guideline No. 41. London (UK): RCOG; 2012. Available at: https://www.rcog.org.uk/globalassets/documents/guidelines/ gtg_41.pdf. Retrieved July 30, 2018.
  10. Pattanittum P, Kunyanone N, Brown J, et al. Dietary supplements for dysmenorrhoea. Cochrane Database Syst Rev. 2016;3(3):CD002124. doi: 10.1002/14651858.CD002124.pub2
  11. Dun EC, Kho KA, Morozov VV, et al. Endometriosis in adolescents. JSLS. 2015;19(2):e2015.00019. doi: 10.4293/JSLS.2015.00019
  12. Brosens I, Gargett CE, Guo SW, et al. Origins and Progression of Adolescent Endometriosis. Reprod Sci. 2016;23(10):1282–1288. doi: 10.1177/1933719116637919
  13. Audebert A, Lecointre L, Afors K, et al. Adolescent endometriosis: report of a series of 55 cases with a focus on clinical presentation and long-term issues. J Minim Invasive Gynecol. 2015;22(5):834–840. doi: 10.1016/j.jmig.2015.04.001
  14. Bourdel N, Alves J, Pickering G, et al. Systematic review of endometriosis pain assessment: how to choose a scale? Hum Reprod Update. 2015;21(1):136–152. doi: 10.1093/humupd/dmu046
  15. Smorgick N, As-Sanie S. Pelvic Pain in Adolescents. Semin Reprod Med. 2018;36(2):116–122. doi: 10.1055/s-0038-1676088
  16. Sahin N, Kasap B, Kirli U, Yeniceri N, Topal Y. Assessment of anxiety-depression levels and perceptions of quality of life in adolescents with dysmenorrheal. Reprod Health. 2018;15(1):13. doi: 10.1186/s12978-018-0453-3
  17. DiVasta AD, Vitonis AF, Laufer MR, Missmer SA. Spectrum of symptoms in women diagnosed with endometriosis during adolescence vs adulthood. Am J Obstet Gynecol. 2018;218:324.e1–324.e11. doi: 10.1016/j.ajog.2017.12.007
  18. Bahrami A, Avan A, Sadeghnia HR, et al. High dose vitamin D supplementation can improve menstrual problems, dysmenorrhea, and premenstrual syndrome in adolescents. Gynecol Endocrinol. 2018;34(8):659–663. doi: 10.1080/09513590.2017.1423466
  19. Black A, Guilbert E, Costescu D, et al. Canadian Contraception Consensus (Part 3 of 4): Chapter 8 ― Progestin-Only Contraception. J Obstet Gynaecol Can. 2016;38(3):279–300. doi: 10.1016/j.jogc.2015.12.003
  20. Harada T. Dysmenorrhea and endometriosis in young women. Yonago Acta Med. 2013;56(4):81–84.
  21. Sarıdoğan E. Endometriosis in teenagers. Womens Health (Lond). 2015;11(5):705–709. doi: 10.2217/whe.15.58
  22. Boerner KE, Chambers CT, McGrath PJ, LoLordo V, Uher R. The effect of parental modeling on child pain responses: the role of parent and child sex. J Pain. 2017;18(6):702–715. doi: 10.1016/j.jpain.2017.01.007
  23. Volkow ND, McLellan AT. Opioid abuse in chronic pain — misconceptions and mitigation strategies. N Engl J Med. 2016;374(13):1253–1263. doi: 10.1056/NEJMra1507771
  24. Seo J, Lee D, Yoon B, Choi D. The efficacy of postoperative cyclic oral contraceptives after gonadotropin-releasing hormone agonist therapy to prevent endometrioma recurrence in adolescents. J Pediatr Adolesc Gynecol. 2017;30(2):223–227. doi: 10.1016/j.jpag.2016.10.004
  25. Black A, Guilbert E, Costescu D, et al. No. 329-Canadian Contraception Consensus. Part 4 of 4, Chapter 9: Combined Hormonal Contraception. J Obstet Gynaecol Can. 2017;39(4):229–268.e5. doi: 10.1016/j.jogc.2016.10.005
  26. Knox B, Ong YC, Bakar MA, Grover SR. A longitudinal study of adolescent dysmenorrhoea into adulthood. Eur J Pediatr. 2019;178(9):1325–1332. doi: 10.1007/s00431-019-03419-3

Copyright (c) 2021 Eco-Vector

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies